Scarica l'app Stockscreener
97.44
0.93%
0.90
Pre-mercato:
97.69
0.25
+0.26%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$96.54
Aprire:
$96.98
Volume 24 ore:
10.25M
Relative Volume:
1.16
Capitalizzazione di mercato:
$248.54B
Reddito:
$63.17B
Utile/perdita netta:
$12.15B
Rapporto P/E:
54.13
EPS:
1.8
Flusso di cassa netto:
$14.84B
1 W Prestazione:
-1.08%
1M Prestazione:
-10.36%
6M Prestazione:
-25.61%
1 anno Prestazione:
-5.10%
Intervallo 1D:
$96.66
$98.84
Intervallo di 1 settimana:
$94.48
$99.40
Portata 52W:
$94.48
$134.63
Merck Co Inc Stock (MRK) Company Profile
Nome
Merck Co Inc
Settore
Industria
Telefono
908-740-4000
Indirizzo
2000 GALLOPING HILL ROAD, KENILWORTH, NJ
Confronta MRK con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
| MRK | 97.44 | 248.54B | 63.17B | 12.15B | 14.84B | 1.80 |
| LLY | 753.41 | 693.54B | 40.86B | 8.37B | -2.28B | 5.4193 |
| NVO | 105.27 | 465.74B | 39.36B | 13.79B | 9.83B | 2.4077 |
| JNJ | 153.11 | 353.35B | 87.70B | 14.68B | 19.03B | 13.47 |
| ABBV | 167.76 | 294.70B | 55.53B | 5.12B | 15.62B | 3.65 |
Merck Co Inc Stock (MRK) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-10-17 | Iniziato | Bernstein | Mkt Perform |
| 2024-03-11 | Downgrade | Societe Generale | Hold → Sell |
| 2024-01-04 | Aggiornamento | TD Cowen | Market Perform → Outperform |
| 2023-11-09 | Iniziato | Deutsche Bank | Buy |
| 2023-10-27 | Aggiornamento | BMO Capital Markets | Market Perform → Outperform |
| 2023-10-20 | Aggiornamento | UBS | Neutral → Buy |
| 2023-07-14 | Iniziato | HSBC Securities | Hold |
| 2023-04-13 | Aggiornamento | Citigroup | Neutral → Buy |
| 2023-03-28 | Downgrade | Societe Generale | Buy → Hold |
| 2023-03-13 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2023-03-06 | Iniziato | Jefferies | Buy |
| 2023-02-22 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2023-01-04 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2022-11-18 | Iniziato | Credit Suisse | Outperform |
| 2022-10-10 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2022-09-14 | Aggiornamento | Berenberg | Hold → Buy |
| 2022-07-06 | Aggiornamento | Daiwa Securities | Neutral → Buy |
| 2022-06-06 | Ripresa | SVB Leerink | Outperform |
| 2022-04-06 | Ripresa | Morgan Stanley | Equal-Weight |
| 2021-12-17 | Iniziato | Goldman | Buy |
| 2021-12-16 | Iniziato | Daiwa Securities | Neutral |
| 2021-12-13 | Downgrade | UBS | Buy → Neutral |
| 2021-12-09 | Iniziato | Wells Fargo | Overweight |
| 2021-12-07 | Downgrade | Guggenheim | Buy → Neutral |
| 2021-11-29 | Downgrade | Citigroup | Buy → Neutral |
| 2021-11-19 | Iniziato | BMO Capital Markets | Market Perform |
| 2021-11-01 | Aggiornamento | Argus | Hold → Buy |
| 2021-09-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2021-07-27 | Ripresa | Truist | Buy |
| 2021-05-20 | Downgrade | Argus | Buy → Hold |
| 2021-04-07 | Ripresa | RBC Capital Mkts | Sector Perform |
| 2020-11-10 | Ripresa | Bernstein | Outperform |
| 2020-09-29 | Iniziato | Berenberg | Hold |
| 2020-08-03 | Aggiornamento | Goldman | Neutral → Buy |
| 2020-06-12 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2020-02-27 | Iniziato | Barclays | Overweight |
| 2020-01-07 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2019-10-17 | Ripresa | BofA/Merrill | Neutral |
| 2019-08-16 | Iniziato | SVB Leerink | Outperform |
| 2019-07-03 | Iniziato | Mizuho | Buy |
| 2019-05-28 | Iniziato | Goldman | Neutral |
| 2019-05-13 | Aggiornamento | Atlantic Equities | Neutral → Overweight |
| 2018-10-16 | Reiterato | Citigroup | Buy |
| 2018-10-09 | Ripresa | Guggenheim | Buy |
| 2018-04-23 | Aggiornamento | Goldman | Neutral → Buy |
| 2018-04-17 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2018-04-05 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2018-03-12 | Aggiornamento | Leerink Partners | Mkt Perform → Outperform |
| 2018-02-14 | Reiterato | Leerink Partners | Mkt Perform |
| 2018-02-07 | Reiterato | Morgan Stanley | Equal-Weight |
| 2018-01-16 | Aggiornamento | SunTrust | Hold → Buy |
Mostra tutto
Merck Co Inc Borsa (MRK) Ultime notizie
Citizens Financial Group Inc. RI Has $27.79 Million Stock Position in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Ontario Teachers Pension Plan Board Sells 7,664 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Jennison Associates LLC Sells 728,756 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck Foundation Commits $17M to Transform Cardiac Care Access in Underserved Communities | MRK Stock News - StockTitan
Merck & Co., Inc. (MRK)’s Blockbuster Drugs: A Key Player in Ken Griffin’s Portfolio - Insider Monkey
Payden & Rygel Grows Position in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Moran Wealth Management LLC Reduces Stock Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Sold by Grandfield & Dodd LLC - MarketBeat
Connor Clark & Lunn Investment Management Ltd. Sells 792,148 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Commerce Bank Buys 29,422 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Prospera Private Wealth LLC Buys 12,781 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Stake Cut by Northwest Bancshares Inc. - MarketBeat
Strategy Asset Managers LLC Reduces Stock Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Quest Partners LLC Has $1.18 Million Stake in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck says Keytruda injection on par with approved IV version in trial - Reuters
Merck & Co. Inc. stock outperforms competitors despite losses on the day - MarketWatch
Merck & Co.’s Subcutaneous Keytruda Matches I.V. - Scrip
Merck & Co., Inc. (NYSE:MRK) Raises Dividend to $0.81 Per Share - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Down 0.1%Here's Why - MarketBeat
Merck readies new Keytruda version ahead of major regulatory headwinds - Seeking Alpha
Merck's Multi-Billion Dollar Drug Keytruda's Investigational Under The Skin Injection At Par With Intravenous Formulation In Untreated Lung Cancer Patients - Yahoo Finance
Merck & Co. Raises Quarterly Dividend by 5.2% - Marketscreener.com
Merck Increases Quarterly Dividend to $0.81 Per Share, Payable Jan. 8 to Shareholders of Record Dec. 16 - Marketscreener.com
Merck Declares $0.81 Per Share Q1 2025 Dividend, Sets January Payment Date | MRK Stock News - StockTitan
New Millennium Group LLC Has $1.27 Million Stake in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
PNC Financial Services Group Inc. Reduces Stock Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
B. Metzler seel. Sohn & Co. Holding AG Makes New $42.43 Million Investment in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck: success of a subcutaneous version of Keytruda - Marketscreener.com
Fifth Third Wealth Advisors LLC Buys 34,312 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Prospera Financial Services Inc Purchases 9,387 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Stock Holdings Boosted by Smead Capital Management Inc. - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Sold by Meeder Asset Management Inc. - MarketBeat
Merck stock gains on injectable Keytruda trial win (MRK:NYSE) - Seeking Alpha
Pathstone Holdings LLC Sells 7,059 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Belmont Capital LLC Reduces Stake in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Jim Cramer Says Merck & Co., Inc. (MRK) Is ‘Just Way Too Hated’ - Insider Monkey
Merck & Co. Inc. stock rises Monday, still underperforms market - MarketWatch
Merck & Co., Inc. (NYSE:MRK) Trading Down 0.6%What's Next? - MarketBeat
Stocks Flash: Biggest Recent Disappointment (Merck & Co Inc., MRK) and Biggest Bright Spot (Dell Technologies Inc, DELL) - Elliott Wave International
Is Merck & Co., Inc. (MRK) the Best Immunotherapy Stock to Buy Now? - Insider Monkey
Braun Stacey Associates Inc. Sells 7,853 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
AMG National Trust Bank Sells 5,505 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Aljian Capital Management LLC Makes New Investment in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Sold by TrinityPoint Wealth LLC - MarketBeat
Swiss National Bank Has $853.74 Million Stock Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Thrivent Financial for Lutherans Has $208.65 Million Stock Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Concord Asset Management LLC VA Has $5.08 Million Stock Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Mutual of America Capital Management LLC Decreases Stake in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Sold by Mizuho Securities USA LLC - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Stock Holdings Decreased by Natixis Advisors LLC - MarketBeat
Kentucky Retirement Systems Insurance Trust Fund Lowers Stock Position in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck Co Inc Azioni (MRK) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.17%
0.71%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):